Skip to main content

Assay-Ready Organ Network

Project description

Accelerating drug development

The world of drug discovery is exciting but very challenging. Effective drug development starts with cell-based assays research, which involves creating test systems with which to test the efficacy and toxicity of compounds. This makes physiological and predictive pre-clinical in vitro assays essential for new medicines to hit the market. To facilitate the process, the EU-funded ARON project has developed a so-called assay-ready organ network, described as the most advanced modular in vitro assay platform that will set a new standard for a wide range of cell-based, pre-clinical testing. It will shift the organ-on-a-chip technology from a late-stage, luxury service to routinely used ready-to-use assays. Overall, the project aims to reduce costs, time to market and animal testing.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

INSPHERO AG
Net EU contribution
€ 50 000,00
Address
Wagistrasse 27
8952 Schlieren
Switzerland

See on map

Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00